Trials / Unknown
UnknownNCT02282670
A Study to Evaluate the Efficacy and Safety of DA-5204
A Phase III Clinical Trial to Evaluate the Efficacy and Safety of DA-5204 and to Demonstrate the Non-inferiority of DA-5204 Compared With Stillen Tab. in Patients With Acute or Chronic Gastritis
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 434 (actual)
- Sponsor
- Dong-A ST Co., Ltd. · Industry
- Sex
- All
- Age
- 20 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
This is a multicenter, active-controlled, randomized, double-blinded, paralleled group clinical study to evaluate the efficacy and safety of DA-5204 and to demonstrate the non-inferiority of DA-5204 compared with Stillen® tab. in patients with acute or chronic gastritis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | DA-5204 | |
| DRUG | Stillen tab. |
Timeline
- Start date
- 2014-04-01
- Primary completion
- 2014-11-01
- Completion
- 2014-11-01
- First posted
- 2014-11-04
- Last updated
- 2014-11-04
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02282670. Inclusion in this directory is not an endorsement.